Background {#Sec1}
==========

Knee osteoarthritis (KOA) is a degenerative disease with joint pain, stiffness, and function degeneration with a more prevalent incidence among middle- and old-aged groups \[[@CR1], [@CR2]\]. The clinical treatment for KOA patients usually combines drug therapy and non-drug therapy, among which the latter mainly includes exercise and acupuncture, and common KOA drugs include non-steroidal anti-inflammatory drugs, intra-articular glucocorticoid and intra-articular hyaluronic acid \[[@CR3]\]. Although KOA is affected by many factors, the damage of meniscus occurred in the process of reconstruction surgery is a major cause of KOA \[[@CR4]\]. According to statistics, patients with both anterior cruciate ligament (ACL) injury and meniscus injury have an incidence rate of KOA as high as 70% within 15 to 20 years after injury \[[@CR5]\]. It is found that similar to osteoporosis and fracture; reduced cartilage thickness may also be one of the factors that predispose to KOA \[[@CR6]\]. Due to the susceptibility and high incidence of KOA, it is of great importance to find early diagnosis markers of KOA to improve KOA treatment effect \[[@CR2]\].

Cluster of Differentiation 40 (CD40) is a type I trans-membrane glycoprotein composed of 277 amino acids with a molecular weight of 40 \~ 50 kDa \[[@CR7]\]. Human *CD40* gene is located at chromosome 20q11-13, containing eight introns and nine exons \[[@CR8], [@CR9]\]. Through interaction with its ligand CD40L, *CD40* plays an important role in cellular and humoral immunity, and it can activate inflammatory response in the human body and promote the progression of atherosclerosis \[[@CR10], [@CR11]\]. *CD40* rs1883832 C \> T includes CC, CT, and TT genotypes with their promoters located at Kozak region, in which the occurring gene mutation greatly impacts the gene translation efficiency \[[@CR12]\]. At present, a number of studies have found that single nucleotide polymorphisms (SNPs) at *CD40* gene promoter -1 is associated with numerous immuno-inflammatory diseases, such as Graves' disease as well as acute coronary syndrome (ACS) \[[@CR13], [@CR14]\]. Although previously classified as a non-inflammatory arthritis, osteoarthritis (OA) has now been generally recognized as a inflammatory disease \[[@CR15]\]. *CD40* rs1883832 was found associated with biopsy-proven giant cell arteritis (GCA) \[[@CR16]\]. Moreover, the association of rs4810485 G \> T with systemic lupus erythematosus (SLE) has been investigated by many researchers but without consistent results \[[@CR17], [@CR18]\]. Vazgiourakis found that rs4810485 G \> T minor allele T is under-represented in SLE patients and correlates with reduced *CD40* expression \[[@CR19]\]. Nevertheless, the literature investigating association between *CD40* rs4810485 G \> T and rs1883832 C \> T and KOA was limited in numbers. This paper intends to explore the relationship between SNPs in the *CD40* gene (rs4810485 G \> T and rs1883832 C \> T), disease susceptibility and severity in KOA, so as to find an effective target for early diagnosis and treatment of KOA.

Methods {#Sec2}
=======

Ethics statement {#Sec3}
----------------

This study was approved by the Ethics Committee of Xiangya Hospital, Central South University and in accordance with the standards of the National Research Council. Informed consent was obtained from each patient prior to our study.

Study subjects {#Sec4}
--------------

A total of 133 patients diagnosed with KOA in Xiangya Hospital, Central South University from December 2012 to November 2013 were recruited as KOA group, (*n* = 133) comprised of 39 males and 94 females with a mean age of 58.24 ± 9.66 years. KOA diagnosis was in accordance with the KOA criteria laid down by Association of Rheumatology Health Professionals (ARHP) \[[@CR20]\]. Exclusion criteria are as follows: joint diseases caused by other reasons, such as inflammatory arthritis, traumatic arthritis, suppurative arthritis, chronic inflammation, infectious diseases and tumor or skeletal dysplasia; patients with no less than 3 metacarpophalangeal joint involvements that are in grade 2--4 of Kellgren-Lawrence (KL) grading. Another 143 healthy individuals were included into the control group, containing 52 males and 91 females with a mean age of 59 (58.2 ± 6.7) years. Members in the control group underwent clinical examination, and X-ray confirmed that they did not have KOA or other arthritis. They also had no symptoms and signs of related joint diseases such as pain, swelling, tenderness and limited activity, or family history of KOA. All subjects had complete clinical data, including age, sex, body mass index (BMI), smoking and drinking status, heavy physical labor and living environment \[[@CR21]\]. Smoking status was be divided into three categories: (1) never smoking; (2) used to smoke; (3) still smoking. People who are addicted to smoking were excluded from this study as subjects. In China, the light, medium and heavy drinking scales can be defined as 1.3 \~ 20 g, 20 \~ 50 g and \> 50 g of daily alcohol intake. All patients in this study were light or occasional drinkers, indicating daily alcohol intake not exceeding 20 g and 2 \~ 3 times a week. For an 8 h work-day, if the average 8-h energy consumption is no less than 7310.2 J/person and working time ≥ 73%, namely, if the working time is more than 350 min, it can be defined as heavy labor. Living environment is closely related to human life, where light intensity and air humidity are two objective factors affecting living environment, according to which the research subjects can be divided into two types: (1) bright + dry type; (2) damp + dark type.

Criteria for disease severity in KOA {#Sec5}
------------------------------------

In accordance with the severity grading of KOA clinical comprehensive index \[[@CR22]\], six indicators (pain, swelling, walking difficulty, joint friction sound (sense), limitation of activity and X-ray change) were used to assess the KOA severity. According to the accumulative score of each indicator, mild means 6 points, moderate 7 to 11 points, and severe 12 to 18 points. In the KOA group, the mild group is comprised of 49 cases, moderate group 44 cases, and severe group 40 cases. Patients in the mild group exhibited no obvious symptoms; instead they usually felt joint stiffness, knee coldness or discomfort which could be slightly improved after activity. In the moderate group, patiens showed acute knee inflammation after violent activity, which was relieved by rest or symptomatic treatment. Knee ache and discomfort occurred when sitting up and symptoms were relieved after walking for a while. Patients in the severe group had unbearable knee pain, and had difficulty of going upstairs and downstairs, as well as squatting or standing. A long walk would cause swelling in the knee joint with some mucus. Moving their knees would cause a sound along with limitation of activity, joint deformity and even potential crippling.

Polymerase chain reaction--restriction fragment length polymorphism (PCR-RFLP) {#Sec6}
------------------------------------------------------------------------------

Based on the genomic data of Chinese Han population in HapMap, this study was conducted as follows: literature review was done before searching for Tag-SNP and FAST SNP \[[@CR23]\] to find the functional mutation sites of *CD40* gene. At last, rs4810485 G \> T and rs1883832 C \> T were identified as the polymorphic loci that were detected in this study (Additional file [1](#MOESM1){ref-type="media"}: Figure S1). On the day of admission, 2 mL of peripheral venous blood was extracted from the subjects before 9 AM. Blood samples were anti-coagulated with ethylenediaminetetraacetic acid (EDTA). DNA was extracted using phenol-chloroform extraction method; the concentration was determined and then preserved at -70 °C. DNA fragments of rs4810485 G \> T and rs1883832 C \> T were amplified with their DNA as the template respectively. Primer was designed with the bio-software Primer Premier 5.0 (Premier, Pala Alto, CA, USA). The upstream primer sequence of rs4810485 G \> T was 5'-ATCCCCCAAGTACCTGGCTCCT-3' and the downstream was 5'-CCTTGCTGCTTCCCTTGCTTTC-3'. The upstream primer sequence of rs1883832 C \> T was 5'-CCTCTTCCCCGAAGTCTTCC-3' and the downstream was 5'-GAAACTCCTGCGCGGTGAAT-3'. The volume of PCR amplification reaction was 20 μL, containing 2.0 μL of 10 × PCR buffer, 2.0 μL of 0.3 mmol/L dNTPs, 1.0 μL of upstream (10 μM) and downstream primers (10 μM) respectively, 1.0 μL of template DNA (2.5 ng/μL), 1.0 U of TaqDNA polymerase. The lack of 20 μL volume could be supplemented by ddH~2~O. Reaction conditions for rs4810485 G \> T were a total of 42 cycles of denaturation for 30 s at 94 °C, annealing for 35 s at 56 °C, extending for 45 s at 72 °C, and extending for 10 min at 72 °C as the end of reaction with 320 bp product. PCR amplification product of 10 μL was dealt with by 5 U restriction endonuclease SfaNI in water for 5 h at 37 °C. Reaction conditions for rs1883832 C \> T were pre-denatured for 5 min at 94 °C, then a total of 35 cycles of denaturation for 30 s at 94 °C, annealing for 45 s at 61 °C, extending for 45 s at 72 °C, and at last extending for 10 min at 72 °C. PCR amplification product of 10 μL was cleaved at rs1883832 C \> T by 5 U restriction endonuclease NcoI, and reaction lasted for 6 h at 37 °C. Shrimp alkaline phosphatase (Promega Corporation, Madison, WI, USA) and exonuclease I (Epicentre) were used to purify PCR product, then SNaPshot Multiplex kit (ABI Company, Oyster Bay, NY, USA) was used for extending reaction, and Promega was used to purify the product of extension. The samples were loaded in ABl3130XL and SNP typing was conducted through GeneMapper4.0 (ABI Company, Oyster Bay, NY, USA).

Statistical analysis {#Sec7}
--------------------

The statistical analyses were conducted with SPSS21.0, and measurement data were presented by mean ± standard deviation (SD). Data consistent with normal distribution was analyzed using *t*-test and variance analysis, and data not conforming to normal distribution was analyzed using rank-sum test. Enumeration data were presented by number or ratio, differences between groups were analyzed using Chi-Square Test; multiple sets of data were analyzed using partition of chi-square test, and rank sum test was used to compare genotypes of different severities. Binary logistic regression analysis was used to analyze the risk factors related to disease severity of KOA. Disease severity of KOA was taken as the dependent variable, and rs4810485 G \> T, rs1883832 C \> T, age, gender, BMI, smoking status, alcohol consumption, heavy labor and living environment were taken as the independent variable. Odds ratios (OR), 95% confidential interval (CI), and *P*-value were calculated. *P* \< 0.05 was considered statistically significant.

Results {#Sec8}
=======

Comparisons of baseline characteristics between the KOA group and the control group {#Sec9}
-----------------------------------------------------------------------------------

There was no significant difference in age, gender, BMI, smoking status, alcohol consumption, and heavy labor between the KOA group and the control group (all *P* \> 0.05). The percentage of patients who had lived in a damp and dark environment was much higher in the KOA group than in the control group (89.47% vs. 6.99%). Therefore, living environment was an external factor affecting KOA (Table [1](#Tab1){ref-type="table"}).Table 1Comparisons of baseline characteristics between the KOA group and the control groupBaseline characteristicKOA groupControl group*P*(*n* = 133)(*n* = 143)Age (year)58.24 ± 9.6656.72 ± 9.430.187Gender (case)0.214 Male3952 Female9491BMI (kg/m^2^)23.60 ± 3.0722.95 ± 2.820.068Smoking status (%) Never100 (75.19)102 (71.33)0.577 Ever8 (6.02)7 (4.90) Still25 (18.8)34 (23.78)Alcohol consumption (%) Yes48 (36.09)48 (33.57)0.660 No85 (63.91)95 (66.43)Heavy labor (%)37 (27.82)39 (27.27)0.919Living environment\<0.001 Good (Bright + dry)14 (10.53)133 (93.01) Poor (Dark + damp)119 (89.47)10 (6.99)*Note*: *KOA* Knee osteoarthritis, *BMI* Body mass index

The DNA sequencing analysis of *CD40* gene {#Sec10}
------------------------------------------

Agarose gel electrophoresis of PCR-amplified products showed that rs4810485 G \> T was a 320 bp single band before enzyme cleavage. And after enzyme cleavage, G/G homozygote was a 320 bp band (GG genotype); G/T heterozygote included 136 bp, 183 bp, and 320 bp bands (GT genotype); T/T homozygote included 136 bp and 183 bp bands (TT genotype) (Fig. [1a](#Fig1){ref-type="fig"}). The results of DNA sequencing were consistent with those tested by PCR-RFLP. PCR-amplified products at rs1883832 C \> T were 302 bp. According to the restriction enzyme NcoI fragments, there were three genotypes (Fig. [1b](#Fig1){ref-type="fig"}): two bands for CC genotype (169 bp, 133 bp), three bands for CT genotype (302 bp, 169 bp, and 133 bp), and one band for TT genotype (302 bp). Confirmed by DNA sequencing, they were consistent with the results of enzyme digestion.Fig. 1Electrophoresis map of *CD40* rs4810485 G \> T and rs1883832 C \> T. Note: **a**, *CD40* rs4810485 G \> T polymorphism: 1 and 5, GG genotype; 2 and 4, TT genotype; 3 and 6, GT genotype; **b**, *CD40* rs1883832 C \> T polymorphism: 1 and 5, TT genotype; 2 and 6, CT genotype; 3 and 4, CC genotype; *CD40*, Cluster of Differentiation 40

Comparisons of genotype frequency distributions and allele frequencies of CD40 rs4810485 G \> T and rs1883832 C \> T between the KOA and control groups {#Sec11}
-------------------------------------------------------------------------------------------------------------------------------------------------------

Genotype distributions and allele frequencies of rs4810485 G \> T and rs1883832 C \> T in the KOA group and the control group are shown in Table [2](#Tab2){ref-type="table"}. Genotype distributions of all polymorphisms were found to conform to Hardy-Weinberg equilibrium (*P* \> 0.05), indicating that the population was well represented. The KOA group was significantly different from the control group in genotype distribution and allele frequency of rs4810485 G \> T (*P* \< 0.05). Compared with patients carrying GG genotype, patients with TT genotype had significantly lower risk of KOA (GG vs TT: OR = 0.194, 95%CI = 0.097 \~ 0.387, *P \<* 0.001). The susceptibility to KOA in individuals carrying T allele significantly decreased compared with those carrying G allele (G vs T: OR = 0.410, 95%CI = 0.290 \~ 0.577, *P* \< 0.001), indicating that homozygous TT genotype and T allele may be protective factors for KOA. Besides, patients with rs1883832 C \> T TT genotype had increased susceptibility to KOA compared with CC genotype (CC vs TT: OR = 2.914, 95%CI = 1.413 \~ 6.010, *P =* 0.003), which suggests that rs1883832 C \> T T allele and mutant homozygous TT genotype increased the susceptibility to KOA.Table 2Comparisons of genotype distributions and allele frequencies of *CD40* rs4810485 G \> T and rs1883832 C \> T between the KOA and control groupsSNPKOA groupControl groupχ2*P*OR (95%CI)rs4810485 G \> T GG44 (33.08%)21 (14.69%)Ref. GT63 (47.37%)58 (40.56%)4.2260.0400.518 (0.276 \~ 0.974) TT26 (19.55%)64 (44.76%)22.95\< 0.0010.194 (0.097 \~ 0.387) GT + TT89 (66.92%)122 (85.31%)12.95\< 0.0010.348 (0.194 \~ 0.627) G allele151 (57.14%)100 (34.97%)Ref. T allele115 (42.86%)186 (65.03%)26.42\< 0.0010.410 (0.290 \~ 0.577)rs1883832 C \> T CC21 (15.79%)43 (30.07%)Ref. CT75 (56.39%)74 (51.75%)5.5530.0192.075 (1.124 \~ 3.830) TT37 (27.82%)26 (18.18%)8.5950.0032.914 (1.413 \~ 6.010) CT + TT96 (72.18%)117 (81.82%)0.0821.680 (0.934 \~ 3.024) C allele117 (43.98%)160 (55.94%)Refer T allele149 (56.02%)126 (44.06%)7.8840.0051.617 (1.155 \~ 2.264)*Note*: *CD40* Cluster of Differentiation 40, *KOA* Knee osteoarthritis, *OR* Odds ratio, *CI* Credibility interval, *SNP* Single nucleotide polymorphism

Correlation analysis between SNPs in *CD40* gene and clinical characteristics of KOA patients {#Sec12}
---------------------------------------------------------------------------------------------

The correlation of rs4810485 G \> T and rs1883832 C \> T with KOA patients' age, gender, BMI, smoking status, alcohol consumption, and heavy labor is shown in Table [3](#Tab3){ref-type="table"}. No significant difference was found between different genotypes of rs4810485 G \> T and rs1883832 C \> T with age, gender, BMI, smoking status, alcohol consumption and heavy labor (all *P* \> 0.05).Table 3Correlations of *CD40* rs4810485 G \> T and rs1883832 C \> T polymorphisms with clinical characteristics of KOA patientsClinical characteristicrs4810485 G \> T*P*rs1883832 C \> T*P*GG (44)GT (63)TT (26)CC (37)CT (75)TT (21)Age0.8580.883  \< 61 years25 (56.82)39 (61.90)16 (61.54)13 (61.90)46 (61.33)21 (56.76)  ≥ 61 years19 (43.18)24 (38.10)10 (38.46)8 (38.10)29 (38.67)16 (43.24)Gender0.2300.300 Male16 (36.36)14 (22.22)9 (34.62)8 (38.10)18 (24.00)13 (35.14) Female28 (63.64)49 (77.78)17 (65.38)13 (61.90)57 (76.00)24 (64.86)BMI (kg/m^2^)0.1070.086 19 ≤ Y ≤ 2633 (75)52 (82.54)16 (61.54)12 (57.14)59 (78.67)30 (81.08)33 (75) Y \< 19 or Y \> 2611 (25)11 (17.46)10 (38.46)9 (42.86)16 (21.33)7 (18.92)11 (25)Smoking status (%)0.6990.289 Yes10 (22.7)11 (17.46)4 (15.38)4 (19.05)11 (14.67)10 (27.03) No34 (77.3)52 (82.54)22 (84.62)17 (80.95)64 (85.33)27 (72.97)Alcohol consumption (%)0.9110.943 Yes17 (38.61)22 (34.92)9 (34.62)7 (33.33)27 (36.00)14 (37.84) No27 (61.36)41 (65.08)17 (65.38)14 (66.67)48 (64.00)23 (62.16)Heavy labor10 (22.73)19 (30.16)8 (30.77)0.6537 (33.33)18 (24.00)12 (32.43)0.534*Note*: *CD40* Cluster of Differentiation 40, *KOA* Knee osteoarthritis, *BMI* Body mass index

The relationship between *CD40* gene polymorphism and KOA severity {#Sec13}
------------------------------------------------------------------

The correlation analysis between different genotypes and KOA severity is shown in Table [4](#Tab4){ref-type="table"}. There were significant differences in genotype and allele distributions of rs4810485 G \> T and rs1883832 C \> T among the mild, moderate and severe groups (all *P* \< 0.05). There were more patients with rs4810485 G \> T GG genotype and rs1883832 C \> T TT genotype in the severe group than other genotypes of these two SNPs.Table 4The relationship between *CD40* rs4810485 G \> T and rs1883832 C \> T polymorphisms and the disease severity of KOASNPSevereModerateMildχ2*P*(*n* = 40)(*n* = 44)(*n* = 49)rs4810485 G \> T GG26 (63.41)10 (23.26)8 (16.33) GT11 (27.5)24 (54.5)28 (57.1)25.38\< 0.001 TT4 (10.00)9 (20.5)13 (26.53) G allele63 (78.75)44 (50.00)44 (44.90) T allele19 (23.75)42 (47.73)54 (55.10)20.17\< 0.001rs1883832 C \> T CC3 (7.32)7 (16.28)11 (22.4) CT20 (48.78)25 (58.14)30 (61.22)10.110.039 TT18 (43.90)11 (25.58)8 (16.33) C allele26 (32.50)39 (44.32)52 (53.06) T allele56 (70.00)47 (53.41)46 (46.94)8.3580.015*Note*: *CD40* Cluster of Differentiation 40, *KOA* Knee osteoarthritis, *SNP* Single nucleotide polymorphism

Binary logistic regression analysis for disease severity of KOA {#Sec14}
---------------------------------------------------------------

Binary logistic regression analysis was performed and the results showed that rs4810485 G \> T and rs1883832 C \> T were both related to KOA. TT genotype of rs4810485 G \> T could alleviate disease severity of KOA while TT genotype of rs1883832 C \> T increases the severity of KOA (both *P* \< 0.05). Age, gender, BMI, smoking status, alcohol consumption and heavy labor had little impact on the severity of KOA, while living environment is considered an important external factor that affects KOA severity (all *P* \< 0.05) (Table [5](#Tab5){ref-type="table"}).Table 5Binary logistic regression analysis for the disease severity of KOAVariablesBS.E.WaldDf*P*Exp (B)95% CIrs4810485 TT−1.5280.6126.23810.0130.2170.065 \~ 0.720rs1883832 TT1.3330.6713.94210.0473.7931.017 \~ 14.140Age0.6010.461.70310.1921.8240.740 \~ 4.496Gender0.4390.4940.78910.3741.5510.589 \~ 4.085BMI0.4210.5950.49910.4801.5230.474 \~ 4.892Smoking status0.2950.2781.12510.2891.3430.779 \~ 2.317Alcohol consumption−0.0610.4910.01510.9010.9410.359 \~ 2.465Heavy labor−0.0060.526010.9910.9940.355 \~ 2.788Living environment−3.4911.139.53810.0020.0300.003 \~ 0.279*Note*: *KOA* Knee osteoarthritis, *BMI* Body mass index, *B* Beta, *S.E.* Standard error, *CI* Credibility interval

Discussion {#Sec15}
==========

Osteoarthritis is the world's most common inflammatory joint disease and one of the main causes of disability \[[@CR24]\]. KOA is a kind of osteoarthritis that greatly impacts the life quality of patients \[[@CR25]\]. KOA is a main cause of constant knee pain. According to statistics, majority of people suffer from frequent knee pain, which leads to the limitation of joint function and activity \[[@CR26]\]. In recent years, with people's deepening awareness about the impact of genetic factors on the KOA onset, the role of gene polymorphism in the occurrence and development of KOA has attracted widespread attention \[[@CR27]\]. This paper intends to explore the correlation of gene polymorphism of *CD40* rs4810485 G \> T and rs1883832 C \> T with disease susceptibility and severity in KOA.

First, this study found that, patients who had lived in damp and dark environments had a higher risk of suffering from KOA, suggesting that living environment is an external factor, which was related with the severity of KOA. A previous study has confirmed damp living environment as one of the risk factors for KOA \[[@CR28]\]. Therefore, improvement of ventilation and lighting of a living environment can also effectively alleviate susceptibility to KOA \[[@CR29]\].

The study found that homozygous TT genotype and T allele of rs4810485 G \> T may be protective factors in the pathogenesis of KOA, while T allele and homozygote TT genotype of rs1883832 C \> T increased the susceptibility to KOA. Besides, there were more patients with rs4810485 G \> T GG genotype and rs1883832 C \> T TT genotype in the severe group than other genotypes of these two SNPs. Our binary logistic regression analysis verified that rs4810485 G \> T TT genotype decreased disease severity of KOA, while rs1883832 C \> T TT genotype increased disease severity of KOA. At present, *CD40* rs4810485 is one of the most studied gene polymorphisms that is closely related to the susceptibility to rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) \[[@CR30], [@CR31]\]. *CD40*, rs1883832 polymorphism can produce high expression of *CD40* by up-regulating the transcription or translation efficiency of *CD40* gene, and the abnormal expression of *CD40* will lead to the increase of pro-inflammatory cytokine and cause diseases \[[@CR16], [@CR32]\]. A recent study in Spanish postmenopausal women pointed out that patients with T allele and TT genotype of *CD40* rs1883832 C \> T have decreased CD40 expression and lowered bone mineral density (BMD) at femoral neck and spine sites, leading to the reduced expression of osteoprotegerin (OPG), thereby increasing the susceptibility to osteopenia or osteoporosis \[[@CR33]\]. Previous evidences showed that KOA patients also have greater BMD and higher OPG levels in the serum and synovial fluid than the normal controls \[[@CR34], [@CR35]\]. In addition, shortage of *CD40* rs4810485 T in RA and SLE is due to decreased expression of *CD40* in peripheral blood mononuclear cells and B cells, while sustained expression of CD40L and elevated expression of *CD40* in RA and SLE patients are the main causes of enhanced activation of humoral and cellular immunity, activation of non-cellular immune target, and eventually disease \[[@CR36]\]. It has been found that in ACS and breast cancer patients, the frequency of CC genotype in *CD40-1* T \> C increased significantly compared to healthy controls, and *CD40-1* T \> C significantly increased the risk of these two diseases \[[@CR37]\].

However it should be disclosed that the mechanism of correlation is not fully understood at present. Although 133 KOA patients and 143 healthy controls were enrolled in this study, the sample size was still not big enough, and multiple risk factors were revealed for KOA in previous researches that we failed to take into considerations due to limited sample and funding, such as meniscectomy and regular sports participation \[[@CR38], [@CR39]\]. Besides, the association between a high CD40 expression and patients with TT genotype of rs1883832 C \> T requires further investigation. In addition, replication and fine mapping of SNP in KOA patients are expected for further research.

Conclusions {#Sec16}
===========

In summary, our results demonstrated that BMI and living environment are external factors for the susceptibility to KOA. TT genotype and T allele of rs4810485 G \> T are protective factors for KOA, while C allele and genotype CC of rs1883832 C \> T can increase the susceptibility of KOA. The results of this study opened a new avenue for investigation that may lend insight into KOA.

Additional file {#Sec17}
===============

Additional file 1: Figure S1.Block diagram of *CD40* rs4810485 G \> T and rs1883832 C \> T. Note: *CD40*, Cluster of Differentiation 40. (EPS 928 kb)
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